Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 736,127 K
  • Annual Income, $ -9,489 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1200 unch
on 01/22/25
0.1259 -4.69%
on 01/14/25
-0.0368 (-23.47%)
since 12/09/24
3-Month
0.1200 unch
on 01/22/25
0.1568 -23.47%
on 12/09/24
+0.0145 (+13.74%)
since 10/10/24
52-Week
0.0908 +32.16%
on 09/25/24
0.2311 -48.07%
on 04/03/24
-0.1231 (-50.64%)
since 01/09/24

Most Recent Stories

More News
Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
FDA's Center for Veterinary Medicine Grants Innocan Pharma a Fee Waiver for 2025

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60

/CNW/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma Announces Private Placement of Units

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma Provides its Annual "State of Research and Development" Update for 2024

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma Announces Encouraging Results from a Safety Assessment Study of LPT-CBD on Minipigs

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma Reports Third Quarter 2024 Financial Results

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan to Direct Full Focus on Following Positive FDA Engagement and Significant Potential Market Demand

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma to Present at the 2024 ThinkEquity Conference

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)
Innocan Pharma to Participate at the ThinkEquity 2024 Investor Conference in New York Also Announces Relaunch of Updated Website for Enhanced Investor Experience

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD...

INNO.CN : 0.1850 (+2.78%)
INNPF : 0.1200 (-4.69%)

Key Turning Points

3rd Resistance Point 0.1200
2nd Resistance Point 0.1200
1st Resistance Point 0.1200
Last Price 0.1200
1st Support Level 0.1200
2nd Support Level 0.1200
3rd Support Level 0.1200

See More

52-Week High 0.2311
Fibonacci 61.8% 0.1775
Fibonacci 50% 0.1610
Fibonacci 38.2% 0.1444
Last Price 0.1200
52-Week Low 0.0908

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar